Sponsored By:
Home
About
Advertising
Promoted Listings
Purchase Data
Weekly Update
Data Licensing
Contact
Schwartz Pharma
is defunct.
Fate: Acquired by UCB, 2006, €4.4B
------------------
If you believe any of this information is incorrect, please
let us know
.